Abstract
Fluorination of metabolic hotspots in a molecule is a common medicinal chemistry strategy to improve in vivo half-life and exposure and, generally, this strategy offers significant benefits. Here, we report the application of this strategy to a series of poly-ADP ribose glycohydrolase (PARG) inhibitors, resulting in unexpected in vivo toxicity which was attributed to this single-atom modification.
Original language | English |
---|---|
Pages (from-to) | 560-562 |
Number of pages | 2 |
Journal | Bioorganic and Medicinal Chemistry Letters |
Volume | 29 |
Issue number | 4 |
Early online date | 2 Jan 2019 |
DOIs | |
Publication status | Published - 15 Feb 2019 |
Keywords
- Ataxia
- Animal welfare
- Toxicophore
Research Beacons, Institutes and Platforms
- Manchester Cancer Research Centre